Pharmaceuticals
Oral Enzyme Therapy Market

Oral Enzyme Therapy Market

Oral Enzyme Therapy Market - Global Industry Analysis 2014 - 2018 and Forecast 2019 - 2029

ID: PMRREP30713

Upcoming

Author : Abhijeet Surwase

Introduction

Oral Enzyme therapy falls under the category of dietary supplements. WHO listed oral enzymes into their list of ‘essential medicines’ and also rated some pancreatic digestive enzymes as a safe to use. Oral enzyme therapy includes various digestive enzymes like proteases, lipase, amylase and many others.

Deficiency of this enzymes is mainly due to increasing incidence of pancreatic cancer, cystic fibrosis and other serious disorders. According to WHO report, 458,918 new cases of pancreatic cancer have been reported worldwide in 2018 and prevalence is expected to increase in future.

Due to changing life style peoples are more interested to consume packaged as well as processed food, this may result into lack of required fiber and results into various digestive disorders and for this, as a preventive measure oral enzyme therapy is preferred, this factor may leads to increase the demand of oral enzymes and anticipated to push the growth of oral enzyme therapy market during forecast period.

Increased prevalence of cystic fibrosis and Shwachman-Diamond syndrome leads to increase the demand of oral enzymes and expected to drive growth of Oral Enzyme Therapy Market. Furthermore, professional and personal stress may also result into various digestive disorders which is further increase the demand of oral enzymes and projected to drive the oral enzyme therapy market during proposed period.

Moreover, public organizations like National Gaucher CARE Foundation are offering financial help to patients and due to this the demand of orally taken enzymes is anticipated to increase near future, this may further expected to propel the growth of oral enzyme therapy market.

On the contrary, lack of supportive evidence that are proving the efficacy of synthetically manufactured oral enzymes is a roadblock to the oral enzyme therapy market’s growth.

Furthermore, various regulatory bodies like U.S FDA continuously implementing various regulations that have to fulfill by manufacturers of digestive enzyme and this may, dampens the growth of the oral enzyme therapy market to some extent.

The key participants operating in the Global Oral Enzyme Therapy Market are:

Metagenics, Inc., Allena pharmaceuticals, Twinlab Corporation, Biotics Research Corporation, Garden Of Life Inc., Matsun Nutrition, Country Life LLC., Food State Inc., Rainbow Light Nutritional Systems Inc., Abbott Nutrition, National Enzyme Company, and others.

Get Free sampleGet Free sample